Literature DB >> 2845287

The influence of aminopyridines on Ca2+-dependent evoked release of acetylcholine from rat cortex slices.

F F Foldes1, N Ludvig, H Nagashima, E S Vizi.   

Abstract

The release of acetylcholine (ACh) elicited by electrical stimulation was investigated in rat brain cortical slices preloaded with 3H-choline. Decreasing the [Ca2+]o from 2.5 to 0.3 mM caused a progressive reduction of the evoked release of ACh. 4-Aminopyridine (4AP) or LF14 [(1,1-dimethyl-3-(4-amino-3-pyridyl)], 4 x 10(-5) M doubled the evoked release of ACh when the [Ca2+]o was 2.5 mM and quadrupled it when it was 0.3 mM, to levels higher than those obtained with 2.5 mM [Ca2+]o alone. This indicates that both 4AP and LF14 decrease the Ca2+ requirements for the evoked release of ACh. The findings of this study indicate that LF14 may be suitable for the symptomatic treatment of senile dementia of Alzheimer's type, presumably caused by dysfunction of cholinergic transmission in the brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845287     DOI: 10.1007/bf00971599

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.

Authors:  H Lundh; S Thesleff
Journal:  Eur J Pharmacol       Date:  1977-04-21       Impact factor: 4.432

2.  Proceedings: Selective inhibition of potassium current in the giant axon of the cockroach.

Authors:  M Pelhate; Y Pichon
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

3.  Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.

Authors:  J C Szerb; G T Somogyi
Journal:  Nat New Biol       Date:  1973-01-24

Review 4.  The aminopyridines.

Authors:  W E Glover
Journal:  Gen Pharmacol       Date:  1982

5.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

6.  Decreases in the release of acetylcholine in vitro with low oxygen.

Authors:  G E Gibson; C Peterson
Journal:  Biochem Pharmacol       Date:  1982-01-01       Impact factor: 5.858

7.  Effect of mono- and diaminopyridines on release of [3H]norepinephrine from isolated guinea-pig atrium.

Authors:  T Sugimori; H Nagashima; E S Vizi; L G Harsing; I Chaudhry; I Lalezari; D Duncalf; P L Goldiner; F F Foldes
Journal:  Neuropharmacology       Date:  1987-06       Impact factor: 5.250

Review 8.  Chemotherapy of cognitive disorders in geriatric subjects.

Authors:  P Goodnick; S Gershon
Journal:  J Clin Psychiatry       Date:  1984-05       Impact factor: 4.384

9.  Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake.

Authors:  C Peterson; G E Gibson
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

10.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

View more
  3 in total

1.  Naltrexone potentiates 4-aminopyridine seizures in the rat.

Authors:  A Mihály; K Bencsik; T Solymosi
Journal:  J Neural Transm Gen Sect       Date:  1990

2.  4-Aminopyridine stimulates B-50 (GAP-43) phosphorylation in rat synaptosomes.

Authors:  F M Heemskerk; L H Schrama; P N De Graan; W H Gispen
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

3.  The pre- and postjunctional components of the neuromuscular effect of antibiotics.

Authors:  E S Vizi; I A Chaudhry; P L Goldiner; Y Ohta; H Nagashima; F F Foldes
Journal:  J Anesth       Date:  1991-01       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.